Organization | Centro Hospitalar do Porto

Centro Hospitalar do Porto Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Porto Portugal (2007)

Organization Overview

First Clinical Trial

2009

NCT03961958

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Centro Hospitalar do Porto | Centro Hospitalar S. João, Porto, Portugal | Centro Hospitalar Universitário do Porto

Active Ingredients

Drugs in Phase 4 Trials (2)

rocuronium (zemuron) (1 trial)

sugammadex (bridion) (1 trial)

Drugs in Phase 3 Trials (1)

polidocanol (asclera) (1 trial)

Drugs in Phase 2 Trials (1)

odiparcil (1 trial)

Drugs in Other Trials (7)

desflurane (suprane) (1 trial)

eslicarbazepine acetate (aptiom) (1 trial)

levobupivacaine (chirocaine) (1 trial)

propofol (diprivan) (2 trials)

ropivacaine (naropin) (2 trials)

sevoflurane (ultane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hemorrhoids (Phase 3)

Mucopolysaccharidoses (Phase 2)

Mucopolysaccharidosis VI (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 11